Cited by 651Cancer-related Molecular PathwaysHeat shock proteins researchUbiquitin and proteasome pathways

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

MDMX: a novel p53‐binding protein with some functional properties of MDM2.

Open access

Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., Jochemsen, A. G.·1996·The EMBO Journal

DOI 10.1002/j.1460-2075.1996.tb00919.xPMC PMC452278

Open this paper in CoChat — free account

Abstract

Here we report the isolation of a cDNA encoding a new p53-associating protein. This new protein has been called MDMX on the basis of its structural similarity to MDM2, which is especially notable in the p53-binding domain. In addition, the putative metal binding domains in the C-terminal part of MDM2 are completely conserved in MDMX. The middle part of the MDMX and MDM2 proteins shows a low degree of conservation. We can show by co-immunoprecipitation that the MDMX protein interacts specifically with p53 in vivo. This interaction probably occurs with the N-terminal part of p53, because the activity of the transcription activation domain of p53 was inhibited by co-transfection of MDMX. Northern blotting showed that MDMX, like MDM2, is expressed in all tissues tested, and that several mRNAs for MDMX can be detected. Interestingly, the level of MDMX mRNA is unchanged after UV irradiation, in contrast to MDM2 transcription. This observation suggests that MDMX may be a differently regulated modifier of p53 activity in comparison with MDM2. Our study indicates that at least one additional member of the MDM protein family exists which can modulate p53 function.

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1996.tb00919.x

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
The P-loop — a common motif in ATP- and GTP-binding proteins
Saraste, M., Sibbald, P. R., & Wittinghofer, A. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90281-f · Cited by 2,099
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949

Show all 59 references

Sorted by citations

Items 201–300 of 651

p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
Li, B., Cheng, Q., Li, Z., & Chen, J. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11255 · Cited by 64
Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis
Xiong, X., Zhao, Y., Tang, F., Wei, D., Thomas, D. G., Wang, X., Liu, Y., Zheng, P., & Sun, Y. (2014) · eLife · doi:10.7554/elife.02236 · Cited by 66
Hdmx and Mdm2 can repress transcription activation by p53 but not by p63
Little, N. A., & Jochemsen, A. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204615 · Cited by 64
Self-citation
Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression
Chen, S., Li, X., Li, Y., Xing, Y., Geng, C., Gao, S., Li, J., Ma, B., Wang, Z., Lu, W., et al. (2022) · Theranostics · doi:10.7150/thno.75444 · Cited by 64
Nitric Oxide-Mediated Inhibition of Hdm2−p53 Binding
Schonhoff, C. M., Daou, M., Jones, S. N., Schiffer, C. A., & Ross, A. H. (2002) · Biochemistry · doi:10.1021/bi026262q · Cited by 63
MDMX inhibits the p300/CBP-mediated acetylation of p53
Sabbatini, P., & McCormick, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902320219077 · Cited by 62
Ensemble-based virtual screening reveals dual-inhibitors for the p53–MDM2/MDMX interactions
Barakat, K., Mane, J. Y., Friesen, D. E., & Tuszyński, J. A. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.12.003 · Cited by 61
Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma
Wang, C., Wang, J., Liu, Z., Ma, X., Wang, X., Jin, H. D., Zhang, X.-P., Fu, D., Hou, L., & Lu, Y. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu015 · Cited by 63
p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer
Mendrysa, S. M., Ghassemifar, S., & Malek, R. A. (2011) · Genes & Cancer · doi:10.1177/1947601911409736 · Cited by 65
Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53
Wang, L., He, G., Zhang, P., Wang, X., Jiang, M. H., & Yu, L. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0099-x · Cited by 60
MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
Chen, L., Li, Z., Zwolińska, A., Smith, M. A., Cross, B. L., Koomen, J. M., Yuan, Z.-M., Jenuwein, T., Marine, J., Wright, K. L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.140 · Cited by 62
Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay
Nozaki, M., Tada, M., Matsumoto, R., Sawamura, Y., Abe, H., & Iggo, R. D. (1998) · Acta Neuropathologica · doi:10.1007/s004010050800 · Cited by 60
Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 59
TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process
Lee, S. S., Fu, N. Y., Sukumaran, S. K., Wan, K. F., Wan, Q., & Yu, V. C. K. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.021 · Cited by 59
Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo
Chen, Z., Lin, Y., Barbieri, E., Burlingame, S., Hicks, J. M., Ludwig, A. D., & Shohet, J. M. (2009) · Neoplasia · doi:10.1593/neo.09466 · Cited by 60
p53 in cancer: A paradigm for modern management of cancer
Steele, R. J., & Lane, D. P. (2005) · The Surgeon · doi:10.1016/s1479-666x(05)80041-1 · Cited by 59
Identification of an Aberrantly Spliced Form of HDMX in Human Tumors: A New Mechanism for HDM2 Stabilization
Giglio, S., Mancini, F., Gentiletti, F., Sparaco, G., Felicioni, L., Barassi, F., Martella, C., Prodosmo, A., Iacovelli, S., Buttitta, F., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0450 · Cited by 58
NMR-Based Determination of the 3D Structure of the Ligand–Protein Interaction Site without Protein Resonance Assignment
Orts, J., Wälti, M. A., Marsh, M., Vera, L., Gossert, A. D., Güntert, P., & Riek, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12391 · Cited by 57
Stress-specific response of the p53-Mdm2 feedback loop
Hunziker, A., Jensen, M. H., & Krishna, S. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-94 · Cited by 59
The p53-mediated cytotoxicity of photodynamic therapy of cancer: Recent advances
Zawacka‐Pankau, J., Krachulec, J., Grulkowski, I., Bielawski, K. P., & Selivanova, G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.07.012 · Cited by 62
MdmX Promotes Bipolar Mitosis To Suppress Transformation and Tumorigenesis in p53-Deficient Cells and Mice
Matijasevic, Z., Steinman, H. A., Hoover, K., & Jones, S. N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01108-07 · Cited by 58
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, T., & Dai, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180009 · Cited by 58
Natural Product MDM2 Inhibitors: Anticancer Activity and Mechanisms of Action
Qin, J., Nag, S. A., Voruganti, S., Wang, W., & Zhang, R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803988910 · Cited by 57
Mdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57
Structural and Functional Basis for Therapeutic Modulation of p53 Signaling
Bassett, E. A., Wang, W., Rastinejad, F., & El‐Deiry, W. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1526 · Cited by 57
p53 ubiquitination by Mdm2: A never ending tail?
Coutts, A. S., Adams, C., & Thangue, N. B. L. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.008 · Cited by 56
C-Abl as a modulator of p53
Levav-Cohen, Y., Goldberg, Z., Zuckerman, V., Grossman, T., Haupt, S., & Haupt, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.152 · Cited by 57
HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity
Phillips, A., Teunisse, A., Lam, S., Lodder, K., Darley, M., Emaduddin, M., Wolf, A., Richter, J., de Lange, J., Verlaan-de Vries, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129726 · Cited by 55
Self-citation
Mdm2 and MdmX as Regulators of Gene Expression
Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 58
Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Sun, X. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.75 · Cited by 56
The evolution of MDM2 family genes
Momand, J. A., Villegas, A., & Белый, В. А. (2011) · Gene · doi:10.1016/j.gene.2011.06.030 · Cited by 55
Susceptibility of p53 Unstructured N Terminus to 20 S Proteasomal Degradation Programs the Stress Response
Tsvetkov, P., Reuven, N. B., Prives, C. L., & Shaul, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040493 · Cited by 55
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer
de Oliveira, G. A. P., Rangel, L. P., da Costa, D. C. F., & Silva, J. L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00097 · Cited by 56
Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development
Steinman, H. A., Hoover, K. L., Keeler, M. L., Sands, A., & Jones, S. N. (2005) · Oncogene · doi:10.1038/sj.onc.1208930 · Cited by 52
Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
Wei, X., Wu, S., Song, T., Chen, L., Gao, M., Borcherds, W., Daughdrill, G. W., & Chen, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603838113 · Cited by 50
Role of Mdm4 in drug sensitivity of breast cancer cells
Lam, S., Lodder, K., Teunisse, A. F. A. S., Rabelink, M. J. W. E., Schutte, M., & Jochemsen, A. G. (2010) · Oncogene · doi:10.1038/onc.2009.522 · Cited by 52
Self-citation
An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge
Perricone, U., Gulotta, M. R., Lombino, J., Parrino, B., Cascioferro, S., Diana, P., Cirrincione, G., & Padova, A. (2018) · MedChemComm · doi:10.1039/c8md00166a · Cited by 54
Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
Yu, D.-H., Xu, Z., Mo, S., Li, Y., Cheng, X., & Qin, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01389 · Cited by 53
A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells
Wang, H., & Yan, C. (2011) · Neoplasia · doi:10.1593/neo.11438 · Cited by 50
Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
Pellegrino, M., Mancini, F., Lucà, R., Coletti, A., Giacchè, N., Manni, I., Arisi, I., Florenzano, F., Teveroni, E., Buttarelli, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0439 · Cited by 49
Myogenin in model pufferfish species: Comparative genomic analysis and thermal plasticity of expression during early development
Fernandes, J. M. O., MacKenzie, M. G., Wright, P. A., Steele, S. L., Suzuki, Y., Kinghorn, J. R., & Johnston, I. A. (2005) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2005.09.003 · Cited by 49
Deregulated signalling networks in human brain tumours
Grzmil, M., & Hemmings, B. A. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.018 · Cited by 49
Interrogation of MDM2 Phosphorylation in p53 Activation Using Native Chemical Ligation: The Functional Role of Ser17 Phosphorylation in MDM2 Reexamined
Zhan, C., Varney, K. M., Yuan, W., Zhao, L., & Lu, W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301255n · Cited by 50
Recent Advances in Validating MDM2 as a Cancer Target
Rayburn, E. R., Ezell, S. J., & Zhang, R. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009789124628 · Cited by 50
TP53-Associated Pediatric Malignancies
Pinto, E. M., Ribeiro, R. C., de Figueiredo, B. C., & Zambetti, G. P. (2011) · Genes & Cancer · doi:10.1177/1947601911409745 · Cited by 49
Probing Origin of Binding Difference of inhibitors to MDM2 and MDMX by Polarizable Molecular Dynamics Simulation and QM/MM-GBSA Calculation
Chen, J., Wang, J., Zhang, Q., Chen, K., & Zhu, W. (2015) · Scientific Reports · doi:10.1038/srep17421 · Cited by 49
Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility
Liu, J., Tang, X., Li, M., Lu, C., Shi, J., Zhou, L., Yuan, Q., & Yang, M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2615-x · Cited by 48
Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein–Protein Interactions
Zhang, S., Lou, J., Li, Y., Zhou, F., Yan, Z., Lyu, X., & Zhao, Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00940 · Cited by 48
MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins.
Yam, C. H., Siu, W. Y., Arooz, T., Chiu, C. H. S., Lau, A. W. S., Wang, X. Q., & Poon, R. Y. C. (1999) · PubMed · Cited by 46
TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma
Liang, J., Xing, D., Li, Z., Shen, J., Zhao, H., & Li, S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5183 · Cited by 46
Role of Mdm2 and Mdmx in DNA repair
Eischen, C. M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw052 · Cited by 45
Expression and Role of p53 in the Retina
Vuong, L., Conley, S. M., & Al‐Ubaidi, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8909 · Cited by 45
Mechanistic validation of a clinical lead stapled peptide that reactivates p53 by dual HDM2 and HDMX targeting
Wachter, F., Morgan, A. M., Godes, M., Mourtada, R., Bird, G. H., & Walensky, L. D. (2016) · Oncogene · doi:10.1038/onc.2016.361 · Cited by 45
HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target
Han, X., Garcia‐Manero, G., McDonnell, T. J., Lozano, G., Medeiros, L. J., Xiao, L., Rosner, G. L., Nguyen, M. H., Fernandez, M., Valentin-Vega, Y. A., et al. (2006) · Modern Pathology · doi:10.1038/modpathol.3800727 · Cited by 45
Identification of a domain within MDMX‐S that is responsible for its high affinity interaction with p53 and high‐level expression in mammalian cells
Rallapalli, R., Strachan, G. D., Tuan, R. S., & Hall, D. J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10535 · Cited by 45
Function and dysfunction of the human oncoprotein MDM2
Deb, S. P. (2002) · Frontiers in bioscience · doi:10.2741/a723 · Cited by 45
Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice
Qu, J., Yang, S., Zhu, Y., Guo, T., Thannickal, V. J., & Zhou, Y. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202033 · Cited by 45
DisruptingTP53 in mouse models of human cancers
Parant, J. M., & Lozano, G. (2003) · Human Mutation · doi:10.1002/humu.10186 · Cited by 47
MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
Marcar, L., Ihrig, B., Hourihan, J. M., Bray, S. E., Quinlan, P., Jordan, L. B., Thompson, A. M., Hupp, T. R., & Meek, D. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127713 · Cited by 42
SOLH, a Human Homologue of theDrosophila melanogaster small optic lobesGene Is a Member of the Calpain and Zinc-Finger Gene Families and Maps to Human Chromosome 16p13.3 nearCATM(Cataract with Microphthalmia)
Kamei, M., Webb, G. C., Young, I. G., & Campbell, H. D. (1998) · Genomics · doi:10.1006/geno.1998.5395 · Cited by 46
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
Li, X., Gohain, N., Chen, S., Li, Y., Zhao, X., Li, B., Tolbert, W. D., He, W., Pazgier, M., Hu, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.010 · Cited by 46
Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads
Tyler, T. J., Durek, T., & Craik, D. J. (2023) · Molecules · doi:10.3390/molecules28073189 · Cited by 42
Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy
Lu, M. M., Miller, P. F., & Lü, X. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.008 · Cited by 42
Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer
Swetzig, W. M., Wang, J., & Das, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7533 · Cited by 44
Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
Wu, C., Pan, Y., Yeh, C., & Lunec, J. (2020) · Biomolecules · doi:10.3390/biom10111474 · Cited by 44
SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes
Chhichholiya, Y., Suryan, A. K., Suman, P., Munshi, A., & Singh, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.793523 · Cited by 44
Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB
Hernández‐Monge, J., Rousset-Roman, A. B., Medina‐Medina, I., & Olivares‐Illana, V. (2016) · Genes & Cancer · doi:10.18632/genesandcancer.120 · Cited by 41
A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis
Zhang, J., Yu, G., Yang, Y., Wang, Y., Guo, M., Yin, Q., Yan, C., Tian, J., Fu, F., & Wang, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106128 · Cited by 43
Anatomy of Mdm2 and Mdm4 in evolution
Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40
Solution structure of the C4 zinc finger domain of HDM2
Yu, G. W., Allen, M. D., Andreeva, A. E., Fersht, A. R., & Bycroft, M. (2005) · Protein Science · doi:10.1110/ps.051927306 · Cited by 40
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescencein situ hybridization
Moch, H., Sauter, G., Gasser, T. C., Bubendorf, L., Richter, J., Presti, J. C., Waldman, F. M., & Mihatsch, M. J. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199804)184:4 · Cited by 64
MdmX inhibits Smad transactivation
Kadakia, M., Brown, T. L., McGorry, M. M., & Berberich, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205993 · Cited by 39
MDM4 (MDMX) and its Transcript Variants
Mancini, F., Conza, G. D., & Moretti, F. (2009) · Current Genomics · doi:10.2174/138920209787581280 · Cited by 40
Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
Chen, Y., Wang, Y.-G., Li, Y., Sun, X., & Dai, M. (2016) · Oncotarget · doi:10.18632/oncotarget.14278 · Cited by 38
MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis
Mancini, F., Gentiletti, F., D'Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311793200 · Cited by 38
Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner
Boutell, C., & Everett, R. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8068-8077.2004 · Cited by 42
Full-length hdmX transcripts decrease following genotoxic stress
Markey, M., & Berberich, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.266 · Cited by 38
MDM2 and MDMX in Cancer and Development
Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 39
Regulation of p53 by ING family members in suppression of tumor initiation and progression
Jafarnejad, S. M., & Li, G. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9329-5 · Cited by 40
Cysteine‐Rich Peptides: Hyperstable Scaffolds for Protein Engineering
González‐Castro, R., Gómez-Lim, M. Á., & Plisson, F. (2020) · ChemBioChem · doi:10.1002/cbic.202000634 · Cited by 38
Functions of MDMX in the Modulation of the p53‐Response
Lenos, K., & Jochemsen, A. G. (2011) · BioMed Research International · doi:10.1155/2011/876173 · Cited by 40
Self-citation
Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis
Benosman, S., Groß, I., Clarke, N., Jochemsen, A. G., Okamoto, K., Loeffler, J., & Gaiddon, C. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402216 · Cited by 38
Self-citation
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Nieto‐Sampedro, M., Valle‐Argos, B., Gómez‐Nicola, D., Fernández‐Mayoralas, A., & Nieto‐Díaz, M. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7685 · Cited by 39
Jab1 as a Mediator of Nuclear Export and Cytoplasmic Degradation of p53
Lee, E., Oh, W., & Song, J. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)17401-2 · Cited by 38
On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: A Brownian dynamics study
ElSawy, K. M., Verma, C. S., Joseph, T. L., Lane, D. P., Twarock, R., & Caves, L. S. D. (2013) · Cell Cycle · doi:10.4161/cc.23511 · Cited by 37
Expression of p14, MDM2, and MDM4 in human retinoblastoma
Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 36
Lactate shuttling links histone lactylation to adult hippocampal neurogenesis in mice
Li, Z., Liang, Z., Qi, H., Luo, X., Wang, M., Du, Z., & Guo, W. (2025) · Developmental Cell · doi:10.1016/j.devcel.2024.12.021 · Cited by 39
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 36
Negative auto-regulators trap p53 in their web
Zhou, X. Y., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 37
Mir‐1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53
Wang, X., & Zhu, J. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12607 · Cited by 36
The physical and functional interaction of NDRG2 with MSP58 in cells
Zhang, J., Liu, J., Li, X., Li, F., Wang, L., Zhang, J., Liu, X., Shen, L., Liu, N., Deng, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.141 · Cited by 36
Verbenalin attenuates hepatic damage and mitochondrial dysfunction in alcohol-associated steatohepatitis by regulating MDMX/PPARα-mediated ferroptosis
Dong, J., Du, C., Xu, C., Wang, Q., Wang, Z., Zeng, F., Qian, Z., Zhang, L., Lv, X., Lei, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116227 · Cited by 35
Alterations of G1‐S checkpoint in chordoma
Naka, T., Boltze, C., Kuester, D., Schulz, T., Schneider‐Stock, R., Kellner, A., Samii, A., Herold, C., Ostertag, H., & Roessner, A. (2005) · Cancer · doi:10.1002/cncr.21296 · Cited by 35
Development of cell‐penetrating peptide‐based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions
Philippe, G. J.-B., Huang, Y., Cheneval, O., Lawrence, N., Zhang, Z., Fairlie, D. P., Craik, D. J., de Araujo, A. D., & Henriques, S. T. (2016) · Biopolymers · doi:10.1002/bip.22893 · Cited by 35
Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth
Steinman, H. A., Sluss, H. K., Sands, A., Pihan, G. A., & Jones, S. N. (2004) · Oncogene · doi:10.1038/sj.onc.1206925 · Cited by 35
MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts
Gentiletti, F., Mancini, F., D'Angelo, M., Sacchi, A., Pontecorvi, A., Jochemsen, A. G., & Moretti, F. (2002) · Oncogene · doi:10.1038/sj.onc.1205137 · Cited by 36
Self-citation
MdmX regulates transformation and chromosomal stability in p53-deficient cells
Matijasevic, Z., Krzywicka-Racka, A., Sluder, G., & Jones, S. N. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6797 · Cited by 34
Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens
Alaseem, A. M. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.101790 · Cited by 36
A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer
Gao, F., Xiong, X., Pan, W., Yang, X., Zhou, C., Yuan, Q., Zhou, L., & Yang, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135647 · Cited by 35
Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development
Zhang, Q., He, X., Chen, L., Zhang, C., Gao, X., Yang, Z., & Liu, G. (2012) · The Journal of Pathology · doi:10.1002/path.4077 · Cited by 34

Authors: Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., & Jochemsen, A. G.
Affiliations: Leiden University (NL)
ORCID: Steegenga, W. T.
Dekker, P.
Jochemsen, A. G.
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1996-10-01
Volume: 15
Issue: 19
Pages: 5349-5357
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1002/j.1460-2075.1996.tb00919.x
PMC: PMC452278
OpenAlex: W1592021885
Cited by: 648
References: 59
Citations by year: 2026: 14 · 2025: 13 · 2024: 14 · 2023: 23 · 2022: 26 · 2021: 20 · 2020: 26 · 2019: 21 · 2018: 19 · 2017: 24 · 2016: 39 · 2015: 16 · 2014: 40 · 2013: 25 · 2012: 36
FWCI: 4.05
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: MDMX, MDM2, p53, p53-binding protein, protein-protein interaction, metal-binding domain, p53 regulation, cDNA cloning
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Nuclear Proteins, Organ Specificity, Protein Binding, Proto-Oncogene Proteins, Recombinant Fusion Proteins, RNA, Messenger, Transcription, Genetic, Transfection, Ultraviolet Rays, Transcriptional Activation, Tumor Suppressor Protein p53, Sequence Homology, Amino Acid, Sequence Analysis, DNA, DNA, Complementary, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MDMX: a novel p53‐binding protein with some functional properties of MDM2.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks